42U-27799-48894
2 vaccinations
7 coded responses
20 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 015 / MA
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Diabetes issues. High blood sugarMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Site: Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Elevated glucose, today 400, ketones neg. able to drink water. On insulin pump, have type 1 diabetes for 42 years & stage 111A kidney diseaseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-02-24
- 2021-02-25
- 2021-02-26
-
2021-03-05
Survey response — day 14, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Elevated glucose of over 400MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose decreased, Pre-existing disease — Feeling: Fair · Site: Swelling · Fever · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Low glucose levels, type 1 diabeticMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
- 2021-03-28
-
2021-04-02
Survey response — day 21, dose 2MedDRA: Fatigue — Feeling: Poor · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — day 28, dose 2MedDRA: Pain in extremity, Self-medication — Feeling: Fair · Be unable to do your normal daily activitiesFree text: L calf pain, no swelling. Have leg elevated & on heating padMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-09-10
-
2022-03-12
Survey response — 12 months, dose 2MedDRA: Acute kidney injury, Acute respiratory failure, Hospitalisation, Hypoxia, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Acute respiratory failure with hypoxia & acute kidney injury diagnosed at (b)(6) ER dept on 2/16/22. Admitted to hospital for IV antibiotic. Discharged into theirHome Care program until 2/23/22. Now just need 1L of O2 at night · Healthcare visit (other): My O2 was60%MedDRA releases: 2024-11 · check-in free text available
-
2022-03-12
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-03-15
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Diabetes issues. High blood sugar
Systemic reaction (other): Elevated glucose, today 400, ketones neg. able to drink water. On insulin pump, have type 1 diabetes for 42 years & stage 111A kidney disease
Release 5 — day 14, dose 1
Symptoms: Elevated glucose of over 400
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Low glucose levels, type 1 diabetic
Release 6 — day 21, dose 2
Symptoms: Fatigue
Release 7 — day 28, dose 2
Symptoms: L calf pain, no swelling. Have leg elevated & on heating pad
Release 11 — 12 months, dose 2
Symptoms: Acute respiratory failure with hypoxia & acute kidney injury diagnosed at (b)(6) ER dept on 2/16/22. Admitted to hospital for IV antibiotic. Discharged into theirHome Care program until 2/23/22. Now just need 1L of O2 at night
Healthcare visit (other): My O2 was60%
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Acute kidney injury | · | · | ✓ |
| SD | Acute respiratory failure | · | · | ✓ |
| SD | Blood glucose increased | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Hypoxia | · | · | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SRO | Blood glucose decreased | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release